Atlas Trials

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Clinical trial NCT06996652 · RECRUITING

Trial details

NCT number
NCT06996652
Sponsor
Yale University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
REM Sleep Behavior Disorder
Start date
2026-08-17
Primary completion
2029-08-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.